Probiotics in the dental practice: A review

Quintessence International

Volumn 46, Issue 3, 2015, Pages 255-264

  Laleman, Isabelle ^a   Teughels, Wim ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Caries; Periodontal disease; Probiotics; Tooth decay

Indexed keywords

PROBIOTIC AGENT;

HUMAN; MOUTH DISEASES;

HUMANS; MOUTH DISEASES; PROBIOTICS;

EID: 85016650497     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: 10.3290/j.qi.a33182     Document Type: Article

References (85)

1. Sugano N. Biological plaque control: novel therapeutic approach to periodontal disease. J Oral Sci 2012;54:1-5.
2. Soares GMS, Figueiredo LC, Faveri M, Cortelli SC, Duarte PM, Feres M. Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs. J Appl Oral Sci Rev FOB 2012;20:295-309.
3. Metchnikoff II. The Prolongation of Life: Optimistic Studies. London: Springer, 1906.
4. Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science 1965;147:747-748.
5. Parker R. Probiotics, the other half of the antibiotic story. Anim Nutr Health 1974;29:4-8.
6. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66:365-378.
7. Havenaar R, Huisin't Veld JHJ. Probiotics: A general view. In: Wood, BJB. Lactic Acid Bacteria in Health and Disease. London: Springer, 1992:151-170.
8. Schaafsma G. State of art concerning probiotic strains in milk products. IDF Nutr News Lett 1996;5:16-18.
9. Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 1999;39:13-126.
10. De Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008;111:1-66.
11. Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 2006;42: 80-87.
12. Nishihara T, Koseki T. Microbial etiology of periodontitis. Periodontol 2000 2004;36:14-26.
13. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43:5721-5732.
14. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135-187.
15. Marsh PD. Dental diseases: are these examples of ecological catastrophes? Int J Dent Hyg 2006;4(Suppl 1):3-10.
16. Marsh PD. Dental plaque as a biofilm and a microbial community: implications for health and disease. BMC Oral Health 2006;6(Suppl 1):S14.
17. Devine DA, Marsh PD. Prospects for the development of probiotics and prebiotics for oral applications. J Oral Microbiol 2009;1:1-11.
18. McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 2010;16:2202-2222.
19. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998;16:292-307.
20. Hickson M. Examining the evidence for the use of probiotics in clinical practice. Nurs Stand R Coll Nurs G B 1987 2013;27:35-41.
21. Ciorba MA. A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol 2012;10:960-968.
22. Pattani R, Palda VA, Hwang SW, Shah PS. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med 2013;7: 56-67.
23. Ford AC, Quigley EMM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol 2014;109:1547-1561.
24. Kim S-O, Ah Y-M, Yu YM, Choi KH, Shin W-G, Lee J-Y. Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2014;113:217-226.
25. King S, Glanville J, Sanders ME, Fitzgerald A, Varley D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br J Nutr 2014;112:41-54.
26. Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, et al. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis 2014;17:519-527.
27. Kassayová M, Bobrov N, Strojný L, et al. Preventive effects of probiotic bacteria Lactobacillus plantarum and dietary fiber in chemically-induced mammary carcinogenesis. Anticancer Res 2014;34:4969-4975.
28. Bodean O, Munteanu O, Cirstoiu C, Secara D, Cirstoiu M. Probiotics: a helpful additional therapy for bacterial vaginosis. J Med Life 2013;6:434-436.
29. Segawa S, Wakita Y, Hirata H, Watari J. Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice. Int J Food Microbiol 2008;128:371-377.
30. Teughels W, Loozen G, Quirynen M. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? J Clin Periodontol 2011;38(Suppl 11):159-177.
31. Anderson MH, Shi W. A probiotic approach to caries management. Pediatr Dent 2006;28:151-153.
32. Fejerskov O, Kidd EAM. Dental Caries: the disease and its clinical management. Chichester: John Wiley & Sons, 2008.
33. Fejerskov O. Changing paradigms in concepts on dental caries: consequences for oral health care. Caries Res 2004;38:182-191.
34. Caufield PW, Li Y, Dasanayake A. Dental caries: an infectious and transmissible disease. Compend Contin Educ Dent 2005;26:10-16.
35. Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev 1986;50:353-380.
36. Hajishengallis G, Michalek SM. Current status of a mucosal vaccine against dental caries. Oral Microbiol Immunol 1999;14:1-20.
37. Tanzer JM, Livingston J, Thompson AM. The microbiology of primary dental caries in humans. J Dent Educ 2001;65:1028-1037.
38. Cagetti MG, Mastroberardino S, Milia E, Cocco F, Lingström P, Campus G. The use of probiotic strains in caries prevention: a systematic review. Nutrients 2013;5:2530-2550.
39. Laleman I, Detailleur V, Slot DE, Slomka V, Quirynen M, Teughels W. Probiotics reduce mutans streptococci counts in humans: a systematic review and meta-analysis. Clin Oral Investig 2014;18:1539-1552.
40. Näse L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 2001;35:412-420.
41. Stecksen-Blicks C, Sjostrom I, Twetman S. Effect of long-term consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: A cluster-randomized study. Caries Res 2009;43:374-381.
42. Petersson LG, Magnusson K, Hakestam U, Baigi A, Twetman S. Reversal of primary root caries lesions after daily intake of milk supplemented with fluoride and probiotic lactobacilli in older adults. Acta Odontol Scand 2011;69:321-327.
43. Stensson M, Koch G, Coric S, et al. Oral administration of Lactobacillus reuteri during the first year of life reduces caries prevalence in the primary dentition at 9 years of age. Caries Res 2014;48:111-117.
44. Taipale T, Pienihäkkinen K, Alanen P, Jokela J, Söderling E. Administration of Bifidobacterium animalis subsp. lactis BB-12 in early childhood: a post-trial effect on caries occurrence at four years of age. Caries Res 2013;47:364-372.
45. Hasslöf P, West CE, Karlsson Videhult F, Brandelius C, Stecksén-Blicks C. Early intervention with probiotic Lactobacillus paracasei F19 has no long-term effect on caries experience. Caries Res 2013;47:559-565.
46. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992;63:322-331.
47. Haffajee AD, Arguello EI, Ximenez-Fyvie LA, Socransky SS. Controlling the plaque biofilm. Int Dent J 2003;53(Suppl 3):191-199.
48. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 2006;30:55-60.
49. Twetman S, Derawi B, Keller M, Ekstrand K, Yucel-Lindberg T, Stecksen-Blicks C. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand 2009;67:19-24.
50. Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J Oral Microbiol 2010;2, doi:10.3402/jom.v2i0.5344.
51. Iniesta M, Herrera D, Montero E, et al. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. J Clin Periodontol 2012;39:736-744.
52. Hallström H, Lindgren S, Yucel-Lindberg T, Dahlén G, Renvert S, Twetman S. Effect of probiotic lozenges on inflammatory reactions and oral biofilm during experimental gingivitis. Acta Odontol Scand 2013;71:828-833.
53. Vicario M, Santos A, Violant D, Nart J, Giner L. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial. Acta Odontol Scand 2013;71:813-819.
54. Szkaradkiewicz AK, Stopa J, Karpinski TM. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis [Epub ahead of print, 9 Feb 2014]. Arch Immunol Ther Exp (Warsz).
55. Teughels W, Durukan A, Ozcelik O, Pauwels M, Quirynen M, Haytac MC. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol 2013;40:1025-1035.
56. Riccia DND, Bizzini F, Perilli MG, et al. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis 2007;13:376-385.
57. Shimauchi H, Mayanagi G, Nakaya S, et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: A randomized, doubleblind, placebo-controlled study. J Clin Periodontol 2008;35:897-905.
58. Shah MP, Gujjari SK, Chandrasekhar VS. Evaluation of the effect of probiotic (inersan®) alone, combination of probiotic with doxycycline and doxycycline alone on aggressive periodontitis: a clinical and microbiological study. J Clin Diagn Res 2013;7:595-600.
59. Mayanagi G, Kimura M, Nakaya S, et al. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol 2009;36:506-513.
60. Slawik S, Staufenbiel I, Schilke R, et al. Probiotics affect the clinical inflammatory parameters of experimental gingivitis in humans. Eur J Clin Nutr 2011;65:857-863.
61. Staab B, Eick S, Knöfler G, Jentsch H. The influence of a probiotic milk drink on the development of gingivitis: a pilot study. J Clin Periodontol 2009;36:850-856.
62. Zahradnik RT, Magnusson I, Walker C, McDonell E, Hillman CH, Hillman JD. Preliminary assessment of safety and effectiveness in humans of ProBiora3, a probiotic mouthwash. J Appl Microbiol 2009;107:682-690.
63. Vandekerckhove B, Van den Velde S, De Smit M, et al. Clinical reliability of non-organoleptic oral malodour measurements. J Clin Periodontol 2009;36:964-969.
64. Dadamio J, Van Tornout M, Van den Velde S, Federico R, Dekeyser C, Quirynen M. A novel and visual test for oral malodour: first observations. J Breath Res 2011;5:046003.
65. Seemann R, Bizhang M, Djamchidi C, Kage A, Nachnani S. The proportion of pseudo-halitosis patients in a multidisciplinary breath malodour consultation. Int Dent J 2006;56:77-81.
66. Quirynen M, Dadamio J, Van den Velde S, et al. Characteristics of 2000 patients who visited a halitosis clinic. J Clin Periodontol 2009;36:970-975.
67. Tonzetich J. Direct gas chromatographic analysis of sulphur compounds in mouth air in man. Arch Oral Biol 1971;16:587-597.
68. Tonzetich J. Production and origin of oral malodor: a review of mechanisms and methods of analysis. J Periodontol 1977;48:13-20.
69. Yaegaki K, Sanada K. Volatile sulfur compounds in mouth air from clinically healthy subjects and patients with periodontal disease. J Periodontal Res 1992;27:233-238.
70. Seemann R, Conceicao MD, Filippi A, et al. Halitosis management by the general dental practitioner: results of an international consensus workshop. J Breath Res 2014;8:017101.
71. Kang M-S, Kim B-G, Chung J, Lee H-C, Oh J-S. Inhibitory effect of Weissella cibariaisolates on the production of volatile sulphur compounds. J Clin Periodontol 2006;33:226-232.
72. Masdea L, Kulik EM, Hauser-Gerspach I, Ramseier AM, Filippi A, Waltimo T. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol 2012;57:1041-1047.
73. Lee S-H, Baek D-H. Effects of Streptococcus thermophilus on volatile sulfur compounds produced by Porphyromonas gingivalis. Arch Oral Biol 2014;59:1205-1210.
74. Burton JP, Chilcott CN, Tagg JR. The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis 2005;11(Suppl 1):29-31.
75. Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 2006;100:754-764.
76. Iwamoto T, Suzuki N, Tanabe K, Takeshita T, Hirofuji T. Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: an open-label pilot trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:201-208.
77. Suzuki N, Yoneda M, Tanabe K, et al. Lactobacillus salivarius WB21-containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:462-470.
78. Keller MK, Bardow A, Jensdottir T, Lykkeaa J, Twetman S. Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour. Acta Odontol Scand 2012;70:246-250.
79. Sutula J, Coulthwaite LA, Thomas LV, Verran J. The effect of a commercial probiotic drink containing Lactobacillus casei strain Shirota on oral health in healthy dentate people. Microb Ecol Health Dis 2013;24: doi: 10.3402/mehd. v24i0.21003.
80. Hatakka K, Ahola AJ, Yli-Knuuttila H, et al. Probiotics reduce the prevalence of oral candida in the elderly: a randomized controlled trial. J Dent Res 2007;86:125-130.
81. Sharma A, Rath GK, Chaudhary SP, Thakar A, Mohanti BK, Bahadur S. Lactobacillus brevis CD2 lozenges reduce radiation-and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer 2012;48:875-881.
82. Niscola P, Tendas A, Scaramucci L, Giovannini M, Trinchieri V, De Fabritiis P. Aphthous oral ulceration and its successful management by Lactobacillus brevis CD2 extract in an adult haemophilic patient. Haemophilia 2012;18:78-79.
83. Boyle RJ, Robins-Browne RM, Tang MLK. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 2006;83:1256-1264.
84. Snydman DR. The safety of probiotics. Clin Infect Dis 2008;46(Suppl 2):S104-S111.
85. Pham LC, Hoogenkamp MA, Exterkate RAM, et al. Effects of Lactobacillus rhamnosus GG on saliva-derived microcosms. Arch Oral Biol 2011;56:136-147.